RGEN
Repligen Corporation
Stock
$181.70+4.47 (+2.52%)Close Oct 2, 2026
- EBITDA, 2025
- $134M
- YoY, 2025
- +287.5%
- 5-year CAGR
- +6.7%
- 10-year CAGR
- +22.0%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $134M | +287.5% |
| 2024 | $35M | −70.3% |
| 2023 | $116M | −57.8% |
| 2022 | $276M | +34.0% |
| 2021 | $206M | +112.3% |
| 2020 | $97M | +70.1% |
| 2019 | $57M | +36.4% |
| 2018 | $42M | +70.4% |
| 2017 | $25M | +15.0% |
| 2016 | $21M | +16.1% |
| 2015 | $18M | +24.8% |
| 2014 | $15M | −43.4% |
| 2013 | $26M | +78.1% |
| 2012 | $15M | — |
| 2011 | $1.3M | — |
| 2010 | −$4.4M | — |